2004
DOI: 10.1007/s00213-004-1920-9
|View full text |Cite
|
Sign up to set email alerts
|

Sigma receptors: biology and therapeutic potential

Abstract: More than 20 years after the identification of the sigma receptors as a unique binding site in the brain and in the peripheral organs, several questions regarding this receptor are still open. Only one of the subtypes of the receptor has been cloned to date, but the endogenous ligand still remains unknown, and the possible association of the receptor with a conventional second messenger system is controversial. From the very beginning, the sigma receptors were associated with various central nervous system dis… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

5
230
1
1

Year Published

2005
2005
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 218 publications
(238 citation statements)
references
References 182 publications
(196 reference statements)
5
230
1
1
Order By: Relevance
“…In addition, the relative selectivities of UMB24 and (±)-SM 21 were determined for dopamine, opioid, and phencyclidine sites on NMDA receptors because many historic σ receptor ligands interact with them (Guitart et al, 2004). The affinities of these compounds for 5-HT 2 receptors were also examined because antagonists at these sites are capable of attenuating the toxicity of cocaine (Ritz and George, 1997).…”
Section: Radioligand Binding Studiesmentioning
confidence: 99%
See 1 more Smart Citation
“…In addition, the relative selectivities of UMB24 and (±)-SM 21 were determined for dopamine, opioid, and phencyclidine sites on NMDA receptors because many historic σ receptor ligands interact with them (Guitart et al, 2004). The affinities of these compounds for 5-HT 2 receptors were also examined because antagonists at these sites are capable of attenuating the toxicity of cocaine (Ritz and George, 1997).…”
Section: Radioligand Binding Studiesmentioning
confidence: 99%
“…σ Receptors are unique proteins with an amino acid sequence, drug selectivity pattern, and anatomical distribution that is distinctly different from other mammalian proteins (Guitart et al, 2004;Matsumoto et al, 2003). There are two established subtypes, σ 1 and σ 2 , which are localized in many motor, limbic, and endocrine regions of the brain (Bouchard and Quirion, 1997).…”
Section: Introductionmentioning
confidence: 99%
“…The benzomorphan (+)pentazocine displays several hundred-fold selectivity for the former whereas DTG binds nearly equally well at both populations. The σ 1 receptor has been recently cloned from several sources including human brain; σ 2 receptors have yet to be cloned (reviewed: Guitart et al, 2004). A very recent review (Guitart et al, 2004) describes the potential involvement of σ receptors in schizophrenia, movement disorders, depression, anxiety, drug abuse, and pain.…”
Section: Introductionmentioning
confidence: 99%
“…The σ 1 receptor has been recently cloned from several sources including human brain; σ 2 receptors have yet to be cloned (reviewed: Guitart et al, 2004). A very recent review (Guitart et al, 2004) describes the potential involvement of σ receptors in schizophrenia, movement disorders, depression, anxiety, drug abuse, and pain. For general reviews of early investigations with σ receptors and σ receptor ligands, the reader is referred to: Abou-Gharbia et al, 1993;Chavkin, 1990;Domino and Kamenka, 1988;Itzhak, 1994;Itzhak and Stein, 1990;Junien and Leonard, 1989;Musacchio et al, 1989;Quirion et al, 1987;Snyder and Largent, 1989;Walker et al, 1990.…”
Section: Introductionmentioning
confidence: 99%
“…6 이러한 시그마-1 수용체는 학습과 기 억 이상, 우울증, 정신분열증, 및 약물남용과 같은 중추신경 계 내의 다양한 신경 생리학적 현상에서 중요한 역할을 담당 한다. 4,7,8 시그마-1 수용체의 내인성 리간드는 아직까지 정확히 규명 되지 않은 상태이며, trace amine과 환각성 물질인 dimethyltryptamine (DMT)와 같은 체내 물질들이 내인성 리간 드로 작용할 것으로 추측된다. 9 그 중 pregnenolone 및 dehydroepiandrosterone (DHEA)을 포함한 신경스테로 이드도 시그마-1 수용체를 활성화 시키는 내인성 리간드로 작용하는 것으로 보고 되었다.…”
unclassified